Dobutamine stress-induced microparticle release: A sign of health?

Circulation Research

Volumn 114, Issue 1, 2014, Pages 15-17

  Williams, Brandon M ^a   Williams, Julie C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

cell derived microparticles; Editorials

Indexed keywords

BETA ADRENERGIC RECEPTOR; DOBUTAMINE; GLYCOPHORIN A; LIPOCORTIN 5;

ANGIOCARDIOGRAPHY; ARTERY LESION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELLULAR STRESS RESPONSE; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DOBUTAMINE STRESS ECHOCARDIOGRAPHY; EDITORIAL; ENDOTHELIAL MICROPARTICLE; ERYTHROCYTE MEMBRANE; HEART INFARCTION; HEART STRESS; HUMAN; MEMBRANE MICROPARTICLE; PARTICLE SIZE; PHARMACOLOGIC STRESS TESTING; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RISK ASSESSMENT; STABLE ANGINA PECTORIS; STRESS ECHOCARDIOGRAPHY; UNSTABLE ANGINA PECTORIS; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 84892930036     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.113.302908     Document Type: Editorial

References (21)

1. Heidenreich PA, Trogdon JG, Khavjou OA, et al; Committee AHAAC, Council S, Intervention CoCRa, Cardiology CoC, Prevention CoEa, Arteriosclerosis Co, Biology TaV, Cardiopulmonary Co, Care C, Resuscitation Pa, Nursing CoC, Disease CotKiC, Council on Cardiovascular Surgery and Anesthesia aICoQoCaOR. Forecasting the future of cardiovascular disease in the united states: a policy statement from the American Heart Association. Circulation. 2011;123:933-944
2. Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res. 2011;108:1284-1297.
3. Viera AJ, Mooberry M, Key NS. Microparticles in cardiovascular disease pathophysiology and outcomes. J Am Soc Hypertens. 2012;6:243-252.
4. Tushuizen ME, Diamant M, Sturk A, Nieuwland R. Cell-derived mic-roparticles in the pathogenesis of cardiovascular disease: friend or foe? Arterioscler Thromb Vasc Biol. 2011;31:4-9.
5. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost. 2009;101:439-451.
6. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2005;45:1622-1630.
7. Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, Ahn YS. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension. 2003;41:211-217.
8. Ueba T, Nomura S, Inami N, Nishikawa T, Kajiwara M, Iwata R, Yamashita K. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men. J Atheroscler Thromb. 2010;17:342-349.
9. Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, de Marchena E, Ahn YS. High levels of circulating endothelial mi-croparticles in patients with acute coronary syndromes. Am Heart J. 2003;145:962-970.
10. Bernal-Mizrachi L, Jy W, Fierro C, Macdonough R, Velazques HA, Purow J, Jimenez JJ, Horstman LL, Ferreira A, de Marchena E, Ahn YS. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol. 2004;97:439-446.
11. Chaar V, Romana M, Tripette J, Broquere C, Huisse MG, Hue O, Hardy-Dessources MD, Connes P. Effect of strenuous physical exercise on circulating cell-derived microparticles. Clin Hemorheol Microcirc. 2011;47:15-25.
12. Maruyama K, Kadono T, Morishita E. Plasma levels of platelet-derived microparticles are increased after anaerobic exercise in healthy subjects. J Atheroscler Thromb. 2012;19:585-587.
13. Augustine D, Ayers LV, Lima E, Newton L, Lewandowski AJ, Davis EF, Ferry B, Leeson P. Dynamic release and clearance of circulating mic-roparticles during cardiac stress. Circ Res. 2014;114:109-113.
14. Bree F, Gault I, d'Athis P, Tillement JP. Beta adrenoceptors of human red blood cells, determination of their subtypes. Biochem Pharmacol. 1984;33:4045-4050.
15. Howell RE, Albelda SM, Daise ML, Levine EM. Characterization of beta-adrenergic receptors in cultured human and bovine endothelial cells. J Appl Physiol (1985). 1988;65:1251-1257.
16. Klysner R, Andersen PH, Geisler A, Winther K. Characterization of the beta-adrenergic receptor on the human platelet: a beta 2-subtype. Acta Pharmacol Toxicol (Copenh). 1984;54:265-269.
17. Abid Hussein MN, Nieuwland R, Hau CM, Evers LM, Meesters EW, Sturk A. Cell-derived microparticles contain caspase 3 in vitro and in vivo. J Thromb Haemost. 2005;3:888-896.
18. Böing AN, Hau CM, Sturk A, Nieuwland R. Platelet microparticles contain active caspase 3. Platelets. 2008;19:96-103.
19. Fadok VA, Henson PM. Apoptosis: giving phosphatidylserine recognition an assist-with a twist. Curr Biol. 2003;13:R655-R657.
20. Marwick TH. Stress echocardiography. Heart. 2003;89:113-118.
21. Lacroix R, Robert S, Poncelet P, Kasthuri RS, Key NS, Dignat-George F; ISTH SSC Workshop. Standardization of platelet-derived micropar-ticle enumeration by fow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost. 2010;8:2571-2574.